The Value of Prognostic Factors for Uterine Cervical Cancer Patients Treated with Irradiation Alone

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2007 Dec 25

PMID 18154683

Citations 14

Authors

Ruta Grigiene

Konstantinas P Valuckas

Eduardas Aleknavicius

Juozas Kurtinaitis

Simona R Letautiene

Affiliations

Soon will be listed here.

Abstract

Background: The aim of our study was to investigate and evaluate the prognostic value of and correlations between preclinical and clinical factors such as the stage of the disease, blood Hb level before treatment, size of cervix and lymph nodes evaluated by CT, age, dose of irradiation and duration of radiotherapy related to overall survival, disease-free survival, local control and metastases-free survival in cervical cancer patients receiving radiotherapy alone.

Methods: 162 patients with International Federation of Gynecology and Obstetrics (FIGO) stage IIA-IIIB cervical carcinoma treated with irradiation were analysed. Univariate and multivariate analyses using the Cox regression model were performed to determine statistical significance of some tumor-related factors.

Results: The Hb level before treatment showed significant influence on overall survival (p = 0.001), desease free survival (p = 0.040) and local control (p = 0.038). The lymph node status (>10 mm) assessed on CT had impact on overall survival (p = 0,030) and local control (p = 0,036). The dose at point A had impact on disease free survival (p = 0,028) and local control (p = 0,021) and the radiotherapy duration had showed significant influence on overall survival (p = 0,045), disease free survival (p = 0,006) and local control (p = 0,033).

Conclusion: Anemia is a significant and independent prognostic factor of overall survival, disease-free survival and local control in cervical cancer patients treated with irradiation. The size of lymph nodes in CT is an independent prognostic factor for overall survival and local control in cervical cancer patients. The size of cervix uteri evaluated by CT has no prognostic significance in cervical cancer patients treated with radiotherapy. The prognostic value of FIGO stage of cervical cancer is influenced by other factors, analyzed in this study and is not an independent prognostic factor.

Citing Articles

Are the Common Genetic 3'UTR Variants in ADME Genes Playing a Role in Tolerance of Breast Cancer Chemotherapy?.

Tecza K, Kalinowska-Herok M, Rusinek D, Zajkowicz A, Pfeifer A, Oczko-Wojciechowska M Int J Mol Sci. 2024; 25(22).

PMID: 39596349 PMC: 11594993. DOI: 10.3390/ijms252212283.

Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer.

Beltran Ponce S, Erickson B, Hall W, Bedi M, Martens M, Siker M J Gastrointest Oncol. 2022; 13(1):185-196.

PMID: 35284138 PMC: 8899735. DOI: 10.21037/jgo-21-482.

Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.

Kang S, Wu J, Li J, Hou Q, Tang B Med Sci Monit. 2022; 28:e934588.

PMID: 35260545 PMC: 8919681. DOI: 10.12659/MSM.934588.

Methylation of gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer.

Li X, Zhou X, Zeng M, Zhou Y, Zhang Y, Liou Y J Cancer. 2021; 12(17):5136-5143.

PMID: 34335930 PMC: 8317535. DOI: 10.7150/jca.57460.

Indications for and complications of transfusion and the management of gynecologic malignancies.

Cybulska P, Goss C, Tew W, Parameswaran R, Sonoda Y Gynecol Oncol. 2017; 146(2):416-426.

PMID: 28528916 PMC: 5527999. DOI: 10.1016/j.ygyno.2017.05.010.

References

Perez C, Grigsby P, Nene S, CAMEL H, Galakatos A, Kao M . Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 1992; 69(11):2796-806. DOI: 10.1002/1097-0142(19920601)69:11<2796::aid-cncr2820691127>3.0.co;2-o. View

Coia L, Won M, Lanciano R, MARCIAL V, Martz K, Hanks G . The Patterns of Care Outcome Study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer. 1990; 66(12):2451-6. DOI: 10.1002/1097-0142(19901215)66:12<2451::aid-cncr2820661202>3.0.co;2-5. View

Ogino I, Okamoto N, Andoh K, Kitamura T, Okajima H, Matsubara S . Analysis of prognostic factors in stage IIB-IVA cervical carcinoma treated with radiation therapy: value of computed tomography. Int J Radiat Oncol Biol Phys. 1997; 37(5):1071-7. DOI: 10.1016/s0360-3016(96)00599-8. View

Barillot I, Horiot J, Pigneux J, Schraub S, POURQUIER H, Daly N . Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys. 1997; 38(5):969-78. DOI: 10.1016/s0360-3016(97)00145-4. View

Scheidler J, Hricak H, Yu K, Subak L, Segal M . Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA. 1997; 278(13):1096-101. View

Perez C, Grigsby P, Chao K, Mutch D, Lockett M . Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys. 1998; 41(2):307-17. DOI: 10.1016/s0360-3016(98)00067-4. View

Toita T, Kakinohana Y, Shinzato S, Ogawa K, Yoshinaga M, Iraha S . Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys. 1999; 43(4):777-82. DOI: 10.1016/s0360-3016(98)00481-7. View

Brewster W, Disaia P, Monk B, Ziogas A, Yamada S, Anton-Culver H . Young age as a prognostic factor in cervical cancer: results of a population-based study. Am J Obstet Gynecol. 1999; 180(6 Pt 1):1464-7. DOI: 10.1016/s0002-9378(99)70038-4. View

Borowsky M, Elliott K, Pezzullo J, Santoso P, Choi W, Choi K . A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Bull Cancer. 2005; 92(2):E19-24. View

10.

Grigiene R, Aleknavicius E, Kurtinaitis J . [Prognostic value of anemia for patients with cervical cancer treated with irradiation]. Medicina (Kaunas). 2005; 41(11):916-24. View

11.

Grogan M, Thomas G, Melamed I, Wong F, Pearcey R, Joseph P . The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer. 1999; 86(8):1528-36. DOI: 10.1002/(sici)1097-0142(19991015)86:8<1528::aid-cncr20>3.0.co;2-e. View

12.

Benedet J, Bender H, Jones 3rd H, Ngan H, Pecorelli S . FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000; 70(2):209-62. View

13.

Green J, Kirwan J, Tierney J, Symonds P, Fresco L, Collingwood M . Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001; 358(9284):781-6. DOI: 10.1016/S0140-6736(01)05965-7. View

14.

Green J, Kirwan J, Tierney J, Symonds P, Fresco L, Williams C . Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2001; (4):CD002225. DOI: 10.1002/14651858.CD002225. View

15.

Kodaira T, Fuwa N, Kamata M, Furutani K, Kuzuya K, Ogawa K . Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy?. Int J Radiat Oncol Biol Phys. 2002; 52(3):627-36. DOI: 10.1016/s0360-3016(01)02685-2. View

16.

Witteveen P, Verhaar M, Jurgenliemk-Schulz I, van Eijkeren M . Update on the treatment of advanced cervical cancer. Crit Rev Oncol Hematol. 2002; 43(3):245-56. DOI: 10.1016/s1040-8428(01)00195-0. View

17.

Aleknaviciene B, Smailyte G, Elaawar B, Kurtinaitis J . [Cervical cancer: recent trends of incidence and mortality in Lithuania]. Medicina (Kaunas). 2002; 38(2):223-30. View

18.

Kodaira T, Fuwa N, Toita T, Nomoto Y, Kuzuya K, Tachibana H . Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 56(3):769-77. DOI: 10.1016/s0360-3016(03)00007-5. View

19.

Taylor M, Carrington B, Davidson S, Swindell R, Lawrance J . Staging of advanced cervical carcinoma using MRI-predictors of outcome after radical radiotherapy. Clin Radiol. 2003; 58(7):532-41. DOI: 10.1016/s0009-9260(03)00114-4. View

20.

Waggoner S . Cervical cancer. Lancet. 2003; 361(9376):2217-25. DOI: 10.1016/S0140-6736(03)13778-6. View